Metallothionein in Oesophagus and Cancer
Author Information
Author(s): Coyle P, Mathew G, Game P A, Myers J C, Philcox J C, Rofe A M, Jamieson G G
Primary Institution: Institute of Medical and Veterinary Science
Hypothesis
The study investigates the potential of metallothionein as a marker for the progression from normal oesophagus through Barrett's epithelium to adenocarcinoma.
Conclusion
Metallothionein is a marker of progression from normal to Barrett's epithelium but is not increased in oesophageal adenocarcinoma.
Supporting Evidence
- Metallothionein concentrations were significantly increased in Barrett's epithelium compared to normal oesophagus.
- In cancer patients, metallothionein levels in adenocarcinoma were not significantly different from normal oesophagus.
- Six out of ten cancer patients had elevated metallothionein concentrations in the metaplastic tissue bordering the adenocarcinoma.
Takeaway
This study looked at a protein called metallothionein in the oesophagus to see if it could help tell if someone is moving from a normal state to a disease called Barrett's oesophagus or cancer. They found that while it can show changes in Barrett's, it doesn't help with cancer.
Methodology
The study involved analyzing metallothionein levels in tissue samples from patients undergoing oesophagectomy and biopsies from patients with Barrett's epithelium.
Potential Biases
There may be observer variability in histological diagnosis.
Limitations
The study may not account for all variables affecting metallothionein levels, and the sample size is relatively small.
Participant Demographics
Patients included those with high-grade dysplasia, adenocarcinoma, and Barrett's syndrome.
Statistical Information
P-Value
<0.004
Statistical Significance
p<0.004
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website